That systemic hypertension is involved in the progression of human renal di
sease is mostly suggested by the way anti-hypertensive treatment affects th
e course of the disease. Clinical evidence has been obtained from observati
onal studies as well as from studies of dietary protein restriction, In add
ition, several trials have compared the effects of different antihypertensi
ve agents, The angiotensin-converting-enzyme inhibitors have the best renop
rotective effect when compared to conventional agents and calcium channel b
lockers. In most studies, ACE-inhibitors approximately halved the risk of p
rogressive renal functional deterioration in patients with non-diabetic nep
hropathies; this protection was associated with a significant reduction in
systemic blood pressure and proteinuria. Statistical analysis, however, als
o suggests a direct effect of ACE-inhibitors on the kidney.